Results 1 - 10 of 22 for PAZOPANIB
  1. Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... the intestines, heart problems, and slow wound healing. Pazopanib (Votrient ® ) Pazopanib is another drug that blocks several tyrosine kinases ...
  3. ... in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq ® ), motesanib (AMG 706), axitinib (Inlyta ® ), ... these other drugs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other types of ...
  4. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Kidney cancer: Bevacizumab (Avastin®) , sorafenib (Nexavar®) , sunitinib (Sutent®) , pazopanib (Votrient®) , temsirolimus (Torisel®) , everolimus (Afinitor®) , axitinib (Inlyta®) Leukemia: ...
  5. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Pamidronate Disodium Panitumumab Panobinostat Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon Alfa-2b PEG-Intron (Peginterferon ...
  6. Snapshot of Adolescent and Young Adult Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly ... preoperative chemoradiation or radiation therapy with and without pazopanib , a targeted therapy that inhibits multiple enzymes involved ...
  7. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is approved for ... for both kidney cancer and neuroendocrine tumors, and pazopanib for kidney cancer. Researchers are exploring the use ...
  8. Drugs Approved for Kidney (Renal Cell) Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Axitinib Bevacizumab Everolimus Inlyta (Axitinib) Nexavar (Sorafenib Tosylate) Pazopanib Hydrochloride Proleukin (Aldesleukin) Sorafenib Tosylate Sunitinib Malate Sutent ( ...
  9. ... grow: Imatinib is used to treat dermatofibrosarcoma protuberans . Pazopanib may be used to treat recurrent and progressive ...
  10. ... drugs are also being looked at, as well. Pazopanib (Votrient ® ) is a targeted therapy drug that, like ...
previous · 1 · 2 · 3 · next
Refine by Type